Meghraj Arvindrao Gore โ€” Chief Executive Officer of Health.Global, Pragmatic CEO

Meghraj Arvindrao Gore

#529
Chief Executive Officer
50
Age
28y
Exp
4y
Tenure
5/10
Risk
๐ŸŽ“ B.E. Chemical Engineering ยท JNEC Maharashtra (MGM University)
๐Ÿ“œ MS IT & MBA ยท University of Denver
๐Ÿ›๏ธ None
CompensationTBP
Personality
Openness โ€” Creativity, curiosity, willingness to try new ideasOpenConscientiousness โ€” Discipline, organization, attention to detailConscExtraversion โ€” Social energy, assertiveness, enthusiasmExtraAgreeableness โ€” Cooperation, trust, empathyAgreeNeuroticism โ€” Emotional sensitivity, stress reactivityNeuro
5
Open
6
Cons
4
Extr
5
Agre
5
Neur
Health.Global
Health.Global
Healthcare ยท Mid Cap
Pace โ€” Speed of execution and decision-making intensityPaceInnovation โ€” Appetite for disruption vs incremental improvementInnovCulture โ€” Organizational culture type and valuesCultrEfficiency โ€” Operational and capital efficiency focusEfficPurpose โ€” Balance of profit motive vs social missionPurpsBrand โ€” External brand positioning and market perceptionBrand
High Growth ยท Performance-Driven
About
Meghraj Arvindrao Gore is the Chief Executive Officer of Health.Global, a Mid Cap company in the Healthcare sector with a market cap of โ‚น8K Cr. A Pragmatic leader with 28 years of experience, he is known for consensus-driven decision-making and organic builder strategy. Guided the organizational structure towards steady growth in healthcare service delivery with a focus on regional market penetration.
FAQ
What is Meghraj Arvindrao Gore's leadership style?
Meghraj Arvindrao Gore is classified as a Pragmatic leader. He is consensus-driven in decision-making, with a empire expander motivation and steady-marathon pace of execution.
What is Meghraj Arvindrao Gore's educational background?
Meghraj Arvindrao Gore holds a B.E. Chemical Engineering from JNEC Maharashtra (MGM University) and a MS IT & MBA from University of Denver.
Who is the CEO of Health.Global?
Meghraj Arvindrao Gore is the Chief Executive Officer of Health.Global. He has been with the company for 4 years and in the current role for 4 years.

Leadership DNA

ArchetypePragmatic
MotivationEmpire Expander
CrisisSteady Hand
DecisionConsensus-Driven
GrowthOrganic Builder
PeopleNumbers Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposeMission-First
CustomerPremium-Niche
EmployerLearning Ground
BrandTechnical-Expert
FocusMarket Expansion
OrientationCross-Industry

Leadership Evidence

โ€œGuided the organizational structure towards steady growth in healthcare service delivery with a focus on regional market penetration.โ€
โšก Crisisโ—โ—โ—โ—‹โ—‹
His consensus-driven style and moderate risk profile suggest a preference for stability and stakeholder reassurance over radical restructuring or aggressive disruption during downturns.
๐ŸŽฏ Motivationโ—โ—โ—โ—‹โ—‹
His primary focus on market expansion within the healthcare sector aligns with a drive for scaling presence and dominance.
๐Ÿ‘ฅ Peopleโ—โ—โ—โ—‹โ—‹
As a pragmatic CEO in the clinical healthcare space, he relies on operational KPIs and metrics to maintain consistent service standards across facilities.
๐Ÿ“ˆ Growthโ—โ—โ—โ—‹โ—‹
His focus on market expansion within his existing healthcare vertical points to deepening capacity rather than aggressive M&A or diversification.
๐Ÿ’ก Innovationโ—โ—โ—โ—โ—‹
HCG focuses on scaling specialized cancer care centers and adopting established medical technologies like robotic surgery rather than pioneering new medical categories.
๐Ÿƒ Paceโ—โ—โ—โ—โ—‹
The company follows a methodical expansion strategy of adding new cancer centers and day-care units to maintain consistent clinical growth.
๐ŸŒฑ Purposeโ—โ—โ—โ—โ—‹
The company is built entirely around the specialized mission of accessible, comprehensive cancer care and oncology-focused patient outcomes.
๐Ÿท๏ธ Brandโ—โ—โ—โ—โ—‹
HCG is defined by its reputation for clinical excellence and specialized expertise in oncology, positioning it as a high-authority medical institution.
๐Ÿค Customerโ—โ—โ—โ—โ—‹
HCG operates as a specialized healthcare provider targeting patients requiring complex oncology treatments rather than general mass-market healthcare.
๐Ÿ’ผ Employerโ—โ—โ—โ—‹โ—‹
As a specialized oncology chain, it attracts medical professionals seeking deep clinical expertise and experience in high-end cancer treatment protocols.
๐Ÿ“‹ Mandate
Rapid infrastructure scaling requires a focus on medical outcomes and patient trust to maintain premium positioning in competitive markets.
๐Ÿข Cultureโ—โ—โ—โ—‹โ—‹
Operates in a high-stakes healthcare delivery model requiring strict standard operating procedures and performance metrics.

Financials

Revenue FY25โ‚น2K Cr
PAT FY25โ‚น44 Cr
Rev CAGR 5Y16.7%
OPM8.5%
NPM2%
ROE4.8%
ROCE7.5%
P/E415.1
Fwd P/E58.1
P/B8.3
D/E177.9
Promoter70.5%
Institutional16.9%
Mkt Capโ‚น8K Cr
Compensation
To Be Published
Data being verified from audited reports